PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12427882-3	2002	Casein zymography was used to determine PA-dependent plasminogen activation in the CSF.	Protactinium	40-42	colony stimulating factor 2	Homo sapiens	83-86	
16752945-5	2006	It is produced by ex vivo exposure of dendritic cell precursors to PA 2024, a recombinant fusion protein composed of the PAP target fused to granulocyte-macrophage colony-stimulating factor (GM-CSF) and incorporated into Dendreon"s proprietary Antigen Delivery Cassette.	Protactinium	67-69	colony stimulating factor 2	Homo sapiens	141-189	
16752945-5	2006	It is produced by ex vivo exposure of dendritic cell precursors to PA 2024, a recombinant fusion protein composed of the PAP target fused to granulocyte-macrophage colony-stimulating factor (GM-CSF) and incorporated into Dendreon"s proprietary Antigen Delivery Cassette.	Protactinium	67-69	colony stimulating factor 2	Homo sapiens	191-197	
8370213-6	1993	Although repeated cultures for bacteria or fungi were negative, PAS stains for CSF sediments showed a large number of yeasts morphologically consistent with a Malassezia species.	Protactinium	64-67	colony stimulating factor 2	Homo sapiens	79-82	
11442492-5	2001	Samples with a high PA (> median of the whole group) were more likely to produce interleukin 3, granulocyte macrophage colony-stimulating factor (GM-CSF), granulocyte CSF (G-CSF) (56%, 43% and 50%) than cells with a low PA (33%, 36% and 36%; n.s.).	Protactinium	20-22	colony stimulating factor 2	Homo sapiens	99-147	
11442492-5	2001	Samples with a high PA (> median of the whole group) were more likely to produce interleukin 3, granulocyte macrophage colony-stimulating factor (GM-CSF), granulocyte CSF (G-CSF) (56%, 43% and 50%) than cells with a low PA (33%, 36% and 36%; n.s.).	Protactinium	20-22	colony stimulating factor 2	Homo sapiens	149-155	
11442492-5	2001	Samples with a high PA (> median of the whole group) were more likely to produce interleukin 3, granulocyte macrophage colony-stimulating factor (GM-CSF), granulocyte CSF (G-CSF) (56%, 43% and 50%) than cells with a low PA (33%, 36% and 36%; n.s.).	Protactinium	20-22	colony stimulating factor 2	Homo sapiens	152-155	
11442492-6	2001	The effect of priming by exogenous GM-CSF or G-CSF was significantly more pronounced in samples with a low PA than in rapidly proliferating samples (P < 0.01).	Protactinium	107-109	colony stimulating factor 2	Homo sapiens	35-41	
12119223-4	2002	GM-CSF-treated patients showed improvement in Pa(O(2))/FI(O(2)) over 5 days (p = 0.02) and increased peripheral blood neutrophils (p = 0.08), whereas alveolar neutrophils decreased (p = 0.02).	Protactinium	46-48	colony stimulating factor 2	Homo sapiens	0-6	
10353694-3	1999	However, GM-CSF did prime the cells for enhanced PA formation in the presence of a secondary stimulus (fMet-Leu-Phe or PAF).	Protactinium	49-51	colony stimulating factor 2	Homo sapiens	9-15	
10353694-4	1999	GM-CSF also caused a time-dependent stimulation of diacylglycerol formation in adherent, but not suspended, cells and elicited a time-dependent stimulation of phosphatidylethanol formation, with a concomitant decrease in the formation of PA only at early (< 7 min) times.	Protactinium	238-240	colony stimulating factor 2	Homo sapiens	0-6	
10353694-8	1999	Taken together the data indicate that GM-CSF rapidly activates PLD in adherent cells, which is responsible for the generation of PA.	Protactinium	129-131	colony stimulating factor 2	Homo sapiens	38-44	
8564710-1	1995	When granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated human neutrophils were challenged with the chemotactic factor fMet-Leu-Phe, it was possible to detect a time-dependent increase in the hydrolytic (as measured by the production of phosphatidic acid, PA) and the transphosphatidylation (as measured by the production of phosphatidylethanol, PEt) activities of phospholipase D in intact cells prelabeled with a radioactive fatty acid.	Protactinium	270-272	colony stimulating factor 2	Homo sapiens	5-53	
8564710-1	1995	When granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated human neutrophils were challenged with the chemotactic factor fMet-Leu-Phe, it was possible to detect a time-dependent increase in the hydrolytic (as measured by the production of phosphatidic acid, PA) and the transphosphatidylation (as measured by the production of phosphatidylethanol, PEt) activities of phospholipase D in intact cells prelabeled with a radioactive fatty acid.	Protactinium	270-272	colony stimulating factor 2	Homo sapiens	55-61	
18137830-0	1949	[Considerations on the behavior of blood and CSF concentrations in children subjected to the introduction of PAS by various routes].	Protactinium	109-112	colony stimulating factor 2	Homo sapiens	45-48